In particular, exploring ALARM expression and function in type II immune conditions such as allergic disease, asthma, or other IL-4- and IL-13-driven pathologies will be important to determine whether this module also contributes to Th2-skewed inflammation. This evidence concerns the gene IL4 and asthma.